Publications by authors named "B Keam"

Claim this Profile
P
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS study.
Hyun Ae Jung, Tae Min Kim, Hye Ryun Kim, Chang Gon Kim, Hee Kyung Ahn, Bhumsuk Keam

Lung Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.
Kevin J Harrington, Ari J Rosenberg, Muh-Hwa Yang, Jessica L Geiger, Marc Oliva, Bhumsuk Keam

Oral Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between multidrug-resistant organism status and quality of end-of-life care in patients with advanced cancer referred to palliative care: a retrospective cohort study with nationwide data linkage.
Jeong-Han Kim, Jiwon Yu, Wantaek Lee, Ye Sul Jeung, Shin Hye Yoo, Bhumsuk Keam

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial).
S Hwang, M H Hong, S H Shin, T Yun, K-W Lee, B Keam

ESMO Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Durvalumab, Doxorubicin, and Ifosfamide in Recurrent and/or Metastatic Pulmonary Sarcomatoid Carcinoma (KCSG LU-19-24).
Miso Kim, Jeonghwan Youk, Tae Min Kim, Gyeong-Won Lee, Dong-Wan Kim, Bhumsuk Keam

Clin Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis